Coronary artery calcium (CAC) scoring is a non-invasive way to visualize calcified atherosclerotic plaque in the coronary arteries. But, so what? Physicians have struggled with what to do with this information and how we might incorporate CAC scores into clinical practice. The BioImage study may provide some insight with a prospective cohort study designed to see whether CAC scores predict incident ASCVD in patients at high risk according to the ACC/AHA pooled cohort equation.
Cardiologist Dr. Josh Levenson of University of Pittsburgh Medical Center takes us through what the evidence means to him and what this trial does to impact ASCVD prevention practices. Come listen to his interview with SGIM EBM Subcommittee Bottom Line author Clark Veet and podcast host Bill Fuller.
Here’s the SGIM EBM Subcommittee’s Bottom Line.
Questions or comments about the bottom line? E-mail Clark Veet at email@example.com.
As always, feel free to reach out to Bill Fuller if you have comments on the podcast itself or would like to get involved!